---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-002726"
form_type: "8-K"
ticker: "TBPH"
cik: "0001583107"
company_name: "Theravance Biopharma, Inc."
filed_at: "2026-01-12T23:59:59+00:00"
generated_at: "2026-05-16T10:52:09.175669+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Theravance Biopharma holds investor meetings with January 2026 corporate slide deck; no new financials or guidance

## Summary
- Management team conducting one-on-one meetings with analysts and investors in San Francisco from Jan 12-15, 2026.
- Slide deck furnished as Exhibit 99.1 contains corporate overview but no material new information beyond prior disclosures.
- Filing under Regulation FD; no financial updates, pipeline changes, or guidance adjustments disclosed.

## SEC filing metadata
- accession: 0001104659-26-002726
- form_type: 8-K
- ticker: TBPH
- cik: 0001583107
- company_name: Theravance Biopharma, Inc.
- filed_at: 2026-01-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1583107/000110465926002726/0001104659-26-002726-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1583107/000110465926002726/tm262807d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-002726
- JSON: https://secwatch.observer/filing/0001104659-26-002726.json
- Plain text: https://secwatch.observer/filing/0001104659-26-002726.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.